Core Scientific (CORZ) Capital Expenditures (2021 - 2026)

Core Scientific (CORZ) has 6 years of Capital Expenditures data on file, last reported at $389.2 million in Q1 2026.

• Quarterly Capital Expenditures rose 363.47% year-over-year to $389.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.0 billion (up 478.23% YoY) and the FY2025 annual result came in at $729.0 million, up 667.68% from the prior year.
• Capital Expenditures rose to $389.2 million in Q1 2026 per CORZ's latest filing, from $279.2 million in the prior quarter.
• The five-year high for Capital Expenditures was $389.2 million in Q1 2026, with the low at -$62.3 million in Q4 2022.
• Average Capital Expenditures over 5 years is $83.0 million, with a median of $22.5 million recorded in 2022.
• Year-over-year, Capital Expenditures tumbled 99.89% in 2023 and surged 247408.16% in 2025.
• Core Scientific's Capital Expenditures stood at -$62.3 million in 2022, then jumped by 118.68% to $11.6 million in 2023, then jumped by 146.96% to $28.8 million in 2024, then jumped by 871.03% to $279.2 million in 2025, then jumped by 39.38% to $389.2 million in 2026.
• Business Quant data shows CORZ's Capital Expenditures at $389.2 million in Q1 2026, $279.2 million in Q4 2025, and $244.5 million in Q3 2025.